다이아제팜

다이아제팜
다이아제팜 구조식 이미지
카스 번호:
439-14-5
한글명:
다이아제팜
동의어(한글):
디아제팜;다이아제팜
상품명:
Diazapam
동의어(영문):
DIAZEPAM;Valium;Diazepan;Condition;Vival;Q-pam;Dialar;Atensine;cristalia;Valrelease
CBNumber:
CB9291762
분자식:
C16H13ClN2O
포뮬러 무게:
284.74
MOL 파일:
439-14-5.mol
MSDS 파일:
SDS

다이아제팜 속성

녹는점
131.5-134.5°C
끓는 점
497.4±45.0 °C(Predicted)
밀도
1.2245 (rough estimate)
굴절률
1.6330 (estimate)
인화점
11 °C
저장 조건
2-8°C
용해도
45%(w/v) 수성 2-히드록시프로필-β-시클로덱스트린: 1.6mg/mL
물리적 상태
A neat solid
산도 계수 (pKa)
3.4(at 25℃)
수용성
50mg/L(25℃)
BCS Class
1
안정성
안정적인. 감광성. 강한 산화제와 호환되지 않습니다.
CAS 데이터베이스
439-14-5(CAS DataBase Reference)
IARC
3 (Vol. Sup 7, 66) 1996
NIST
2H-1,4-benzodiazepin-2-one, 7-chloro-1,3-dihydro-1-methyl-5-phenyl-(439-14-5)
EPA
Diazepam (439-14-5)
안전
  • 위험 및 안전 성명
  • 위험 및 사전주의 사항 (GHS)
위험품 표기 Xn,T,F,Xi
위험 카페고리 넘버 21/22-39/23/24/25-23/24/25-11-36/37/38
안전지침서 36/37-45-36-26-16-7
유엔번호(UN No.) UN 2811 6.1/PG 3
WGK 독일 2
RTECS 번호 DF1575000
위험 등급 6.1(b)
포장분류 III
HS 번호 2933910000
유해 물질 데이터 439-14-5(Hazardous Substances Data)
독성 LD50 oral in rabbit: 328mg/kg
기존화학 물질 KE-05605
그림문자(GHS): GHS hazard pictogramsGHS hazard pictograms
신호 어: Danger
유해·위험 문구:
암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드
H410 장기적 영향에 의해 수생생물에 매우 유독함 수생 환경유해성 물질 - 만성 구분 1 경고 GHS hazard pictograms P273, P391, P501
예방조치문구:
P273 환경으로 배출하지 마시오.
P280 보호장갑/보호의/보안경/안면보호구를 착용하시오.
NFPA 704
0
2 0

다이아제팜 MSDS


7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one

다이아제팜 C화학적 특성, 용도, 생산

화학적 성질

Light Yellow Crystalline Solid

용도

Anxiolitic; muscle relaxant (skeletal); anticonvulsant. Controlled substance (depressant)

일반 설명

Off-white to yellow crystalline powder. Practically odorless. Tasteless at first with a bitter aftertaste.

공기와 물의 반응

Hydrolysis occurs in aqueous solutions with a maximum stability around pH 5. . Insoluble in water.

화재위험

Flash point data for Diazapam are not available; however, Diazapam is probably combustible.

생물학적 활성

Ligand at the GABA A receptor benzodiazepine modulatory site. Anxiolytic, anticonvulsant and sedative/hypnotic agent.

Pharmacokinetics

The second group of antispastic drugs to be developed were the benzodiazepines, typified by diazepam. Diazepam exerts its skeletal muscle relaxant effect by binding as an agonist at the benzodiazepine receptor of the GABAA receptor complex, which enhances GABA potency to increase chloride conductance. The muscle relaxant properties of classical benzodiazepines, such as diazepam, appear to be mediated mainly by the GABAA α2 and α3 subunits. The result is neuronal hyperpolarization, probably at both supraspinal and spinal sites for spasmolytic activity. Its actions are sufficient to relieve spasticity in patients with lesions affecting the spinal cord and in some patients with cerebral palsy.

부작용

Few high-quality clinical trials have evaluated diazepam as a muscle relaxant, but these few suggest that diazepam is no more efficacious than, for example, carisoprodol, cyclobenzaprine, or tizanidine (i.e., efficacy is marginal). Moreover, diazepam produces drowsiness and fatigue in most patients at doses required to significantly reduce muscle tone.

Safety Profile

Poison by ingestion, parenteral, subcutaneous, intravenous, and intraperitoneal routes. Moderately toxic by skin contact. Questionable carcinogen with experimental tumorigenic data. Human systemic effects: dermatitis, effect on inflammation or mediation of inflammation, change in cardiac rate, somnolence, respiratory depression, and other respiratory changes, visual field changes, diplopia (double vision), change in motor activity, muscle contraction or spasticity, ataxia (loss of muscle coordination), an antipsychotic and general anesthetic. Human reproductive effects by ingestion and intravenous routes causing developmental abnormalities of the fetal cardiovascular (circulatory) system and postnatal effects. Experimental teratogenic and reproductive effects. Human mutation data reported. An allergen. A drug for the treatment of anxiety. When heated to decomposition it emits very toxic fumes of Cl and NOx.

신진 대사

Diazepam is rapidly and completely absorbed after oral administration. Maximum peak blood concentration occurs in 2 hours, and elimination is slow, with a half-life of approximately 20 to 50 hours. As with chlordiazepoxide, the major metabolic product of diazepam is N-desmethyldiazepam, which is pharmacologically active and undergoes even slower metabolism than its parent compound. Repeated administration of diazepam or chlordiazepoxide leads to accumulation of N-desmethyldiazepam, which can be detected in the blood for more than 1 week after discontinuation of the drug. Hydroxylation of N-desmethyldiazepam at the 3-position gives the active metabolite oxazepam.

운송 방법

UN2811 Toxic solids, organic, n.o.s., Hazard Class: 6.1; Labels: 6.1-Poisonous materials, Technical Name Required. UN3249 Medicine, solid, toxic, n.o.s., Hazard Class: 6.1; Labels: 6.1-Poisonous materials.

다이아제팜 준비 용품 및 원자재

원자재

준비 용품


다이아제팜 관련 검색:

Copyright 2019 © ChemicalBook. All rights reserved